Biofermin Pharmaceutical. (4517.TSE) Q2 2019 Earnings

24JulExpected
Q3 2018
Q4 2018
Q1 2019
Q2 2019
31.79
37.82
43.84
49.87

Details

Expected EPS
N/A
Actual EPS
40.3156
Surprise EPS
40.32
Surprise Percent
+∞%

Description

Biofermin Pharmaceutical. (4517.TSE) has reported earnings of 40.3156 per share for Q2 2019.

0 Comments

Share your thoughts